India Markets closed
  • BSE SENSEX

    39,614.07
    -135.78 (-0.34%)
     
  • Nifty 50

    11,642.40
    -28.40 (-0.24%)
     
  • USD/INR

    74.5400
    +0.1500 (+0.2016%)
     
  • Dow

    26,501.60
    -157.51 (-0.59%)
     
  • Nasdaq

    10,911.59
    -274.00 (-2.45%)
     
  • BTC-INR

    1,026,001.25
    -5,633.50 (-0.55%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • Hang Seng

    24,107.42
    -479.18 (-1.95%)
     
  • Nikkei

    22,977.13
    -354.81 (-1.52%)
     
  • EUR/INR

    86.8558
    -0.0213 (-0.02%)
     
  • GBP/INR

    96.4408
    +0.2904 (+0.30%)
     
  • AED/INR

    20.2500
    +0.0410 (+0.20%)
     
  • INR/JPY

    1.4012
    -0.0023 (-0.16%)
     
  • SGD/INR

    54.5710
    +0.1180 (+0.22%)
     

OPENING BELL: Sensex rises 170 points, Nifty above 11,550; Lupin jumps 5%, Cipla 3% | September 18

Domestic markets followed Asian peers to open higher in Friday's session, led by gains in RIL, ICICI Bank, TCS, and HDFC Bank. Pharma stocks were buzzing in the morning session, rising up to 10%.

Vodafone Idea, Essel Propack, YES Bank among the most active stocks on NSE. The numbers today in the pharma industries are all in green, Dr. Reddy's Lab stands at 4972. Lupin is at 1075. Cipla stands at 781. Nacto Pharma is at 803.

The entire pharma basket is what is holding up the trade. In pharma industries Q1 numbers were good and the kind of approvals pharma industries received, it is a sector that is roaring currently. There is earnings support, perception change with under ownership.